Biocon to launch new drug in July-Sept quarter
MUMBAI (Reuters) - Biocon(BION.NS), India's top listed biotech firm, plans to launch psoriasis drug Alzumab in the country in the July-September quarter, a top company executive said on Friday.
The company expects sales of 1 billion rupees from the drug over four years, Kiran Mazumdar-Shaw, chairman, Biocon said in a conference call.
Late on Thursday, Biocon reported an 8.24 percent rise in net profit to 920 million rupees for the Oct-Dec quarter compared with a year earlier.
(Reporting by Kaustubh Kulkarni; Editing by Prateek Chatterjee)
- Tweet this
- Share this
- Digg this
- Obama, Modi vow to boost strategic ties, create model for world
- Preview: Basel fans baffled by new coach Sousa's switches
- Preview: Arsenal must now beat Galatasaray, says Cazorla
- Police arrest 140 for religious clashes in Vadodara as Modi tours U.S.
- Modi orders officials to clean loos on Gandhi's birthday
U.S. President Barack Obama and new Indian Prime Minister Narendra Modi vowed on Monday to expand and deepen their countries' strategic partnership and make it a model for the rest of the world. Full Article | Full Coverage
China final HSBC PMI steady in September on stronger global demand but risks remain Full Article
Police arrest 140 for religious clashes in Vadodara as Modi tours U.S. Full Article